Skip to main content

NADT-PROSTATE

The Cancer Imaging Archive

NADT-Prostate | Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

DOI: 10.7937/TCIA.JHQD-FR46 | Data Citation Required | Image Collection

Location Species Subjects Data Types Cancer Types Size Supporting Data Status Updated
Prostate Human 37 Histopathology Prostate Cancer 1.4TB Clinical Public, Complete 2021/10/08

Summary

In order to assess mechanisms predictive of response or resistance to intense neoadjuvant therapy, we performed automated immunohistochemistry on targeted biopsies from patients with intermediate or high risk prostate cancer. All biopsy were stained with H&E or antibodies against: p53, PTEN, AR, PSA, GR, Ki67, SYP and PIN4-cocktail (p63+CK5+K18+AMACR). We further performed automated immunohistochemistry on whole mount radical prostatectomy tissues containing residual tumor. RP tissues were stained with H&E or antibodies against: PTEN, AR, AR-V7, PSA, PSMA, GR, Ki67, SYP and PIN4-cocktail (p63+CK5+K18+AMACR), with some slides stained for other markers of residual tumor, to include NKX3.1 and CAM5.2. Slides were scanned at 20x magnification. For each patient, response to intense neoadjuvant therapy is known. As biopsies were targeted to MRI-visible lesions, lesion-level response to therapy is also known. For each biopsy, gene expression profile by RNA-seq and exome sequencing were performed on tumor tissue laser capture microdissected from serial sections. Up to 4 foci were dissected per biopsy. Whole-genome sequencing of germline DNA from each patient was also performed.

Exome and gene expression data corresponding to pre-treatment biopsy tissues has been deposited in dbGaP and GEO. Genome, exome and expression data from post-treatment radical prostatectomy tissues is underway. As slides were stained using an automated slide stainer, this is a rich resource for performing data mining for assessing histogenomic correlates or signatures of treatment response or resistance.

Data Access

Version 1: Updated 2021/10/08

Title Data Type Format Access Points Subjects Studies Series Images License
Tissue Slide Images from Biopsy Tissue Histopathology TIFF
Download requires IBM-Aspera-Connect plugin
37 1,401 CC BY 4.0
Clinical data XLS CC BY 4.0
Related Datasets
No related Analysis Results found: Submit your proposal! No related Collections found
Legend: Analysis Results| Collections

Additional Resources for this Dataset

The following external resources have been made available by the data submitters.  These are not hosted or supported by TCIA, but may be useful to researchers utilizing this collection.

Citations & Data Usage Policy

Data Citation Required: Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution must include the following citation, including the Digital Object Identifier:

Data Citation

Wilkinson, S., Ye, H., Karzai, F., Harmon, S. A., Terrigino, N. T., VanderWelle, D. J., Bright, J. R., Atway, R., Trostel, S. Y., Carrabba, N. V., Whitlock, N. C., Walker, S. M., Lis, R. T., Sater, H. A., Capaldo, B. J., Madan, R. A., Gulley, J. L., Chun, G., Merino, M. J., … Sowalsky, A. G. (2020). Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/TCIA.JHQD-FR46

Acknowledgements

The authors gratefully acknowledge the patients and the families of patients who contributed to this study.

Related Publications

Publications by the Dataset Authors

The authors recommended this paper as the best source of additional information about this dataset:

  • Wilkinson, S., Ye, H., Karzai, F., Harmon, S. A., Terrigino, N. T., VanderWeele, D. J., Bright, J. R., Atway, R., Trostel, S. Y., Carrabba, N. V., Whitlock, N. C., Walker, S. M., Lis, R. T., Abdul Sater, H., Capaldo, B. J., Madan, R. A., Gulley, J. L., Chun, G., Merino, M. J., … Sowalsky, A. G. (2021). Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. European Urology. https://doi.org/10.1016/j.eururo.2021.03.009

No publications by dataset authors were found.

Publication Citation

Wilkinson, S., Ye, H., Karzai, F., Harmon, S. A., Terrigino, N. T., VanderWeele, D. J., Bright, J. R., Atway, R., Trostel, S. Y., Carrabba, N. V., Whitlock, N. C., Walker, S. M., Lis, R. T., Abdul Sater, H., Capaldo, B. J., Madan, R. A., Gulley, J. L., Chun, G., Merino, M. J., … Sowalsky, A. G. (2021). Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. European Urology. https://doi.org/10.1016/j.eururo.2021.03.009

Research Community Publications

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you’d like to add please contact the TCIA Helpdesk.

Other Publications Using this Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you’d like to add please contact the TCIA Helpdesk.